Perspectum
PrivateLast Round
Grant
Nov 14, 2024
Total Funding Raised
$111.63M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Perspectum is a healthtech company that provides AI-driven medical imaging software and non-invasive diagnostic solutions for patients with liver disease, diabetes, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Clinical Trials, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Perspectum Comparables
Compare Perspectum with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Resonance Health Ltd | 82% | |
| Quibim | 79% | |
| Echosens | 75% | |
Perspectum Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 14, 2024 | ||||
| Series C | Mar 15, 2023 | ||||
| IPO | Aug 6, 2021 | ||||
| Series B | Apr 14, 2020 | ||||
| Grant | Apr 16, 2019 | ||||
Grant | Jan 1, 2019 |
Key People
Founding team and executive leadership
Perspectum Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Barclays PLC | IPO |
| Eureka Network | Grant |
| Oxford Science Enterprises | Series B |
| Westgrove Partners | Series B |
| British Patient Capital | Series C |
| University of Oxford | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 35% MoM, from 10.9K to 14.7K.
- Mar 4, 2026
Maintains ISO 13485 and EU MDR certifications for SaMD products.
Perspectum Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Perspectum's valuation, stock price, and market status.